Position in ABSI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,559,927
+$5,098,348 QoQ
Shares Held
565,999
+16.2% QoQ
Ownership
0.330%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 195 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ABSI ranks #127 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ABSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,559,927 | 565,999 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,461,579 | 487,193 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,095,272 | 313,832 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $837,902 | 275,626 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,799,908 | 1,867,669 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,925,014 | 1,563,751 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $231,075 | 88,197 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $285,433 | 74,721 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $233,254 | 75,732 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $407,040 | 71,662 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $431,172 | 102,660 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $61,225 | 46,383 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,435 | 21,997 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $96,990 | 55,423 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $201,249 | 95,833 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $206,695 | 66,037 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $220,686 | 66,472 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $687,424 | 81,545 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $576,394 | 70,292 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $256,568 | 22,061 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||